STRIDE-II Announcement
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Announcement...
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Leading article in GUT out now! gutjnl-2020-324000.full The COVID-19 pandemic has claimed the lives of nearly 2 million people worldwide.1 Following rapid sequencing of SARS-CoV-2, pharmaceutical companies and academic institutions rapidly generated vaccine candidates...
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients
Special Issue JCC Journal on Covid-19 and IBD – a collaborative work of IOIBD and ECCO. https://academic.oup.com/ecco-jcc/issue/14/Supplement_3 Providing guidance during a global viral pandemic for the care of patients with Inflammatory Bowel Disease Supplement...
SECURE-IBD COVID-19 update #18
A second wave of COVID-19 is experienced in many countries. As of October 27, 2020, a total of 2,797 COVID-19 cases in IBD patients were reported in SECURE-IBD, paralleling this rise in COVID-19. Please continue to spread the word about SECURE-IBD to all of your...
